Oxford patients with sarcoidosis in lungs given new drug
Sarcoidosis can affect people of all ages and can be particularly severe in some cases - with patients often requiring multiple immunosuppressants to treat the condition.It affects about 1 in 10,000 people in the UK, according the charity Sarcoidosis UK.As well as the lungs it can also affect the skin, eyes, joints, nervous system, heart and other parts of the body.Symptoms of pulmonary sarcoidosis include shortness of breath and a persistent dry cough, according to the NHS.
Infliximab reduces the need for patients to rely on immunosuppressants - which can increase the risk of infections and further complications - by targeting a protein produced by overactive immune cells.Ms Hunter said she was "excited about the possibility of reducing the number of medications I need"."I have been on various immunosuppressants for a long time, and the side effects have started to surface," she said."The commissioning of this drug is very welcome news."Prof Ling-Pei Ho, who is a consultant in respiratory medicine at Oxford University Hospitals (OUH), was involved in the work that led to the drug's commissioning."We are very pleased to be able to offer a new medicine for our patients with severe lung sarcoidosis," she said.Chief medical officer at OUH Prof Andrew Brent said that the new drug was "fantastic news" for patients."The commissioning of this drug is a great example of our teams' dedication to continually improving patient care," he added.
You can follow BBC Oxfordshire on Facebook, X (Twitter), or Instagram.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
17 minutes ago
- BBC News
'Magical' event for Bridgwater boy, four, with rare condition
The mother of a four-year-old boy with a rare genetic disorder has described her shock at the community response to an event designed to make him feel "special". Motorbikes, fire engines, police cars and tractors are among the vehicles set to take part in a drive past for Louie, from Bridgwater, later. He is just one of 100 people diagnosed with XIAP deficiency, which can cause a number of complications including an increased risk of developing infections. His mum Shannon, 29, has organised the event ahead of her family having to isolate in preparation for Louie's second bone marrow transplant this autumn. "Never in a million years did I think it would go this crazy, but it just goes to show [there are] strangers all pulling together to make little boys' day," she said. XIAP deficiency largely affects males due to the genetic mutation affecting the X chromosome and Louie was just four months old when he began to display symptoms of the condition, including a was initially suspected that he had cancer after he was blue-lighted to Bristol Children's Hospital from Musgrove Park in Taunton, Somerset. But after extensive investigations, specialists diagnosed him with the rare genetic condition and he was transferred to the care of Great Ormond Street Hospital in London. It was there that he underwent his first bone marrow transplant in August 2023 which, Shannon said, "didn't go very well" and led to Louie developing a brain infection."He lost all mobility, all speech," she said. "He had to relearn to walk, talk - everything again. He's still delayed globally and he struggles with speech now." Louie faces another bone marrow transplant in October - this time with an increased risk of a similar infection despite being closely monitored. "We've got to keep Louis [isolated] throughout September [...] because obviously they don't want him to go in with any type of infection on board," Shannon this in mind, around three weeks ago she said she had the "wild idea" of setting up a "ride-in" event for Louie and his two older brothers Oscar, 12, and Jenson, eight, whose childhoods have been heavily impacted by what Louie has been through. "I wanted to do something special for all three boys because they've all had a tough ride the past few years and they all know what's to come in October," Shannon said. "With Louis obviously being immune compromised we can't really do much as a family," she added. "He's not allowed to go to busy [places] like theme parks, soft plays, literally anything. "He's mainly been around like family kids and family so just for the two older boys [...] just to have that special day and just to feel a bit normal maybe, to have a bit of a childhood and just included - I think it will just be magical for them all." Vehicles of all sizes and shapes, from classic cars to diggers, have been invited to take part in the event, which will set off from Morganians Rugby Club, along the Kingsdown Estate and finishing at Stogursey Village Hall. With hundreds of people sharing her Facebook post and offers of attendance from the fire service and police, Shannon said the response "means everything". "I'm definitely going to be overwhelmed with emotions and the kindness of people," she added.
Western Telegraph
19 minutes ago
- Western Telegraph
Mounjaro prices double as weight loss jab popularity soars
US-based Eli Lilly says a 5mg dose will nearly double from £92 to £180 from September 1, while a 15mg pen will rise from £122 to £330. A Lilly spokesperson said: 'Following a review, Lilly will increase the UK list price for Mounjaro (tirzepatide) from 1 September to address pricing inconsistencies compared to other developed countries, including in Europe. We have reached an agreement with the NHS to ensure continued supply and patient access." The statement continues: 'While Lilly does not determine the prices that private healthcare providers set, we are working with them to maintain patient access. The UK was one of the first countries where Lilly launched Mounjaro, and our priority was to bring it to patients as quickly as possible during a time of limited supply of GLP-1 RA treatments for type 2 diabetes. 'At launch, Lilly agreed to a UK list price that is significantly below the European average to prevent delays in NHS availability." More than 1.5 million people in the UK are believed to be using weight-loss medication each month, with most buying the jabs from private pharmacies. Mounjaro users report surprising side effect - pharmacists share their tips — Bucks Free Press (@bucksfreepress) August 8, 2025 This comes as the Government has joined forces with Eli Lilly in a bid to tackle obesity. The move could see patients accessing care at pharmacies or by using online platforms. The £85 million programme from Eli Lilly and the Department for Science, Innovation and Technology (DSIT) has been designed to look at how obese patients can access weight management care more easily. This includes through community services, in pharmacies and online. Using these tools, eligible patients could be treated 'in a matter of months', according to Health Secretary Wes Streeting. Under the agreement, the Government will contribute up to £50 million in UK-wide investment. Meanwhile, Eli Lilly will back the programme with £35 million, and NHS organisations will be able to apply for a share of the funding. Recommended reading: Mounjaro warning as pens ruined by heatwave temperatures This comes as users are risking having to throw away perfectly good Mounjaro pens as they have overheated in the recent heatwave. Improper storage of Ozempic, Wegovy and Mounjaro during a heatwave could destroy the active ingredient in these jabs, potentially wiping out their effects entirely, even if the medication looks completely normal. 'We recommend treating your weight-loss pen the same way you'd treat insulin or any critical medication,' says Danielle Brightman, Clinical Director at Numan. 'When in doubt, don't risk it. Speak to a healthcare professional and arrange a replacement.' 8 tips to protect Mounjaro and other weight-loss injections during hot weather Use a medical-grade cool bag. Transport your pen in a proper, insulated container designed for sensitive medications. Don't use improvised ice packs that might freeze the pen by accident. Never leave your pen in hot places. Even 10 minutes in a parked car or on a sunny kitchen counter could expose it to damaging heat if out of its delivery packaging or unrefrigerated. Always check the environment before setting it down. Store below 30°C once in use. Once opened and if not refrigerated, keep your pen in a shaded, ventilated area, away from heat sources, windows, and radiators. If you live in a flat or home without air conditioning, keep the pen in a bedroom or hallway that doesn't heat up from direct sun. Avoid storing near exterior walls if the property retains heat. Follow the usage timeline carefully. The storage instructions between medications. Wegovy after first use can last 6 weeks below 30 degrees then needs to be disposed of, whereas Mounjaro has a shorter time of 30 days below 30 degrees before needing to be disposed of. Stick to that timeframe, and if you're unsure whether it's still safe, consult your provider. Use a fridge thermometer at home. Fridge temperatures can fluctuate, especially in older models or over-packed shelves. A simple digital fridge thermometer can help ensure your pen is always stored between 2–8°C before first use. Planning to travel? Use airline-friendly cooling cases. If you're flying or taking long journeys, consider TSA-approved insulated medication pouches with cooling gel packs. Always store the pen in carry-on luggage, not checked baggage, as cargo holds can get hot or cold. Set storage reminders on your phone. If you're prone to forgetting where you left your pen, set daily reminders to check if it's stored properly, especially during heatwaves or while travelling. Don't store near appliances or steam sources. Keep pens away from kettles, toasters, ovens, dishwashers, and anywhere that might experience sudden heat or humidity, especially in small kitchens or shared spaces. Injections like Ozempic, Wegovy, and Mounjaro are now widely used across the UK for appetite control and sustainable weight management. But despite their growing popularity and increasing availability now through the NHS, most patients don't realise the strict temperature guidelines that must be followed to keep these drugs effective. 'We speak to patients every day who are using GLP-1s for the first time,' says Danielle. 'With temperatures set to soar again this summer, it's crucial we raise awareness about safe medication storage. Heat damage isn't always obvious, but it can have a huge impact on effectiveness and safety."
.png%3Fwidth%3D1200%26auto%3Dwebp%26quality%3D75&w=3840&q=100)
Evening Standard
19 minutes ago
- Evening Standard
South London hospital staff set to strike over 'Mickey Mouse' contracts
The workers, all now directly employed by the NHS, are calling for the same pay and conditions as colleagues on the national Agenda for Change (AfC) framework, which sets standard rates for most NHS staff. UVW says that despite being brought back in-house more than four years ago, they still receive lower pay, less annual leave, inferior pensions and no enhancements for night or weekend work.
